Search Results
Assessing FLT3-ITD-specific MRD clearance using a PCR-NGS assay in the QuANTUM-First trial
QuANTUM-First: association between FLT3-ITD-specific MRD clearance and survival in patients with AML
Development of a Novel NGS-Based Assay for MRD in FLT3-ITD AML
Methods to evaluate MRD in AML
Update on QuANTUM-First: quizartinib + SOC chemotherapy & as continuation therapy in FLT3-ITD+ AML
Management of FLT3 positive AML with Dr. Alexander Perl
Sorafenib vs placebo in treatment-naïve FLT3-ITD AML
AML Research: Measuring Residual Disease with Droplet Digital PCR
LBA: gilteritinib as post-transplant maintenance therapy in FLT3-ITD AML
Treatment avenues for patients with R/R FLT3-mutated AML: optimizing FLT3 inhibitors
Prognostic impact of FLT3-ITD in older patients with AML
Insights into the treatment of patients with FLT3-mutated AML & the role of maintenance therapy
